PCI BIOTECH HOLD And ABIVAX On The List Of Winners And Losers Of Thursday’s Euronext Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are PCI BIOTECH HOLD, SOLSTAD OFFSHORE, and SPORTING.

Financial Asset Price Change Updated (EST)
PCI BIOTECH HOLD (PCIB.OL) 2.16 47.95% 2023-09-07 12:42:26
SOLSTAD OFFSHORE (SOFF.OL) 22.00 12.82% 2023-09-07 12:43:45
SPORTING (SCP.LS) 0.92 8.93% 2023-09-07 12:24:35
ELECTROMAGNET GEO (EMGS.OL) 2.66 8.57% 2023-09-07 12:26:38
ARENDALS FOSSEKOMP (AFK.OL) 157.80 8.53% 2023-09-07 12:25:24
GEOJUNXION (GOJXN.AS) 0.88 7.88% 2023-09-07 12:02:32
FOUNTAIN (FOU.BR) 1.23 6.96% 2023-09-07 12:07:05
CARASENT (CARA.OL) 13.38 5.69% 2023-09-07 12:26:17
BPOST (BPOST.BR) 4.71 5.18% 2023-09-07 12:06:04
ADOCIA (ADOC.PA) 10.64 5.14% 2023-09-07 12:45:42

The three biggest losers today are ABIVAX, LAVIDE HOLDING, and ATOS.

Financial Asset Price Change Updated (EST)
ABIVAX (ABVX.PA) 17.38 -8.62% 2023-09-07 12:45:23
LAVIDE HOLDING (LVIDE.AS) 0.21 -6.36% 2023-09-07 12:03:10
ATOS (ATO.PA) 7.41 -5.67% 2023-09-07 12:46:50
NORDIC SEMICONDUC (NOD.OL) 120.10 -5.4% 2023-09-07 12:41:43
BORGESTAD (BOR.OL) 1.41 -5.05% 2023-09-07 12:25:59
KOMPLETT (KOMPL.OL) 9.31 -5% 2023-09-07 12:41:01
ATLANTIC SAPPHIRE (ASA.OL) 1.72 -4.65% 2023-09-07 12:25:32
CELYAD ONCOLOGY (CYAD.BR) 0.79 -4.6% 2023-09-07 12:06:16
REC SILICON (RECSI.OL) 17.01 -4.3% 2023-09-07 12:42:57
MIKO (MIKO.BR) 68.00 -4.23% 2023-09-07 12:20:46

Winners today

1. PCI BIOTECH HOLD (PCIB.OL)

47.95% Price Change

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD jumping 47.95% to €2.16 on Thursday, after five consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI fell 0.6% to €1,262.20, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-1.04.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.97%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

PCI BIOTECH HOLD’s EBITDA is -1.84.

Yearly Top and Bottom Value

PCI BIOTECH HOLD’s stock is valued at kr2.16 at 22:40 EST, way below its 52-week high of kr5.93 and way above its 52-week low of kr1.50.

More news about PCI BIOTECH HOLD.

2. SOLSTAD OFFSHORE (SOFF.OL)

12.82% Price Change

Solstad Offshore ASA operates offshore service vessels and maritime services to offshore energy industry. It owns and operates platform supply vessel, anchor handling tug support vessel, and construction service vessels. The company offers subsea construction and renewable energy services, such as geotechnical work, walk to work services, grouting, SURF operations, cable laying and repair, trenching and burial, ROV support, installation of subsea equipment, survey work, IMR operations, node seismic operations, and diving and topside maintenance work. It operates a fleet of 27 construction service vessels, 20 anchor handling tug support vessels, and 39 platform supply vessels. The company was founded in 1964 and is headquartered in Skudeneshavn, Norway.

Oslo Børs Benchmark Index_GI ended the session with SOLSTAD OFFSHORE jumping 12.82% to €22.00 on Thursday, after two consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI slid 0.6% to €1,262.20, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, SOLSTAD OFFSHORE has a trailing twelve months EPS of kr-3.07.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.43%.

More news about SOLSTAD OFFSHORE.

3. SPORTING (SCP.LS)

8.93% Price Change

Sporting Clube de Portugal – Futebol, SAD operates sports clubs in Portugal. The company also engages in the sale of tickets for games; advertising and sponsorships activities; and provision of television rights. Sporting Clube de Portugal – Futebol, SAD was founded in 1907 and is headquartered in Lisbon, Portugal.

PSI ended the session with SPORTING rising 8.93% to €0.92 on Thursday while PSI slid 0.29% to €6,064.56.

Earnings Per Share

As for profitability, SPORTING has a trailing twelve months EPS of €0.55.

PE Ratio

SPORTING has a trailing twelve months price to earnings ratio of 1.66. Meaning, the purchaser of the share is investing €1.66 for every euro of annual earnings.

Volume

Today’s last reported volume for SPORTING is 370 which is 84.13% below its average volume of 2332.

Moving Average

SPORTING’s value is way above its 50-day moving average of €0.81 and way above its 200-day moving average of €0.79.

Yearly Top and Bottom Value

SPORTING’s stock is valued at €0.92 at 22:40 EST, under its 52-week high of €0.95 and way higher than its 52-week low of €0.65.

Revenue Growth

Year-on-year quarterly revenue growth grew by 19.5%, now sitting on 118.31M for the twelve trailing months.

More news about SPORTING.

4. ELECTROMAGNET GEO (EMGS.OL)

8.57% Price Change

Electromagnetic Geoservices ASA, together with its subsidiaries, provides electromagnetic (EM) surveying services to the offshore oil and gas exploration industry. It is involved in the planning, acquisition, processing, modelling, interpretation, and integration of EM data. The company uses its patented EM survey method to find hydrocarbons in offshore reservoirs. It engages in the provision of controlled-source EM surveying and magneto telluric surveying; imaging and interpretation; rental of software and cluster; and training services. The company has operations in Europe, the Middle East, Africa, Norway, North and South America, Asia, and the Pacific Ocean. Electromagnetic Geoservices ASA was incorporated in 2002 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ELECTROMAGNET GEO rising 8.57% to €2.66 on Thursday while Oslo Børs Benchmark Index_GI slid 0.6% to €1,262.20.

Earnings Per Share

As for profitability, ELECTROMAGNET GEO has a trailing twelve months EPS of kr0.42.

PE Ratio

ELECTROMAGNET GEO has a trailing twelve months price to earnings ratio of 6.33. Meaning, the purchaser of the share is investing kr6.33 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 145.52%.

More news about ELECTROMAGNET GEO.

5. ARENDALS FOSSEKOMP (AFK.OL)

8.53% Price Change

Arendals Fossekompani ASA, an industrial investment company, owns and operates hydropower plants in Norway, rest of Europe, Asia, and North America. The company operates through Hydropower, Group Management, Volue, NSSL Global, ENRX, Tekna, Property, and Alytic segments. It also provides software solutions, systems, and market insight that optimize production, trading, distribution, and consumption of energy, as well as infrastructure and construction projects. In addition, the company manufactures and sells materials for 3D printing for the aerospace, medical, and automotive sectors; and nanomaterials for electronics and batteries industries, as well as offers satellite communications and IT solutions. Further, it delivers green power technology based on induction technology; offers voice and data services; and owns and develops various properties. Arendals Fossekompani is an energy company that mainly delivers energy using natural resources such as water, though it also invests in other asset classes. The firm provides venture capital through its subsidiary and focuses on Norwegian start-ups in the energy, power, and technology industries. Arendals Fossekompani ASA was founded in 1896 and is headquartered in Arendal, Norway.

Oslo Børs Benchmark Index_GI ended the session with ARENDALS FOSSEKOMP rising 8.53% to €157.80 on Thursday, after two sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI slid 0.6% to €1,262.20, following the last session’s downward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, ARENDALS FOSSEKOMP has a trailing twelve months EPS of kr1.06.

PE Ratio

ARENDALS FOSSEKOMP has a trailing twelve months price to earnings ratio of 148.87. Meaning, the purchaser of the share is investing kr148.87 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.07%.

Volume

Today’s last reported volume for ARENDALS FOSSEKOMP is 19081 which is 116.7% above its average volume of 8805.

Revenue Growth

Year-on-year quarterly revenue growth grew by 33.7%, now sitting on 4.93B for the twelve trailing months.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on May 9, 2023, the estimated forward annual dividend rate is 4 and the estimated forward annual dividend yield is 2.56%.

More news about ARENDALS FOSSEKOMP.

6. GEOJUNXION (GOJXN.AS)

7.88% Price Change

GeoJunxion N.V. manufactures and supplies digital maps, premium location content, and location intelligence services worldwide. The company provides location aware content products, including Digital Maps for use in routing, planning, and display services; Geo Location application programming interface (API) that addresses geocoding and time zones covering Europe and North America; and Geo Planning API, which provides time and distance matrices for logistics and resource planning applications, as well as premium location content products, such as Safety Alert Zone that concentrates on road safety by alerting mobility users; Eco Alert Zones, which includes dataset of regulated congestion, emission and restricted traffic zones for use in routing, planning, fleet management, display, real estate applications, and other sectors; and Health Alert Zones that contains COVID-19 related information. It also offers location intelligence services, which includes search and evaluation of location enabled content to enhance existing maps and/or routing applications; creating bespoke datasets; and producing outdoor venue plans for use in events, travel and tourism, real estate applications, last mile navigation and delivery, retail and distribution, and smart city applications, as well as operates GeoAlertsLive application. The company was formerly known as AND International Publishers N.V. GeoJunxion N.V. was founded in 1984 and is headquartered in Capelle aan den IJssel, the Netherlands.

AEX-Index ended the session with GEOJUNXION rising 7.88% to €0.88 on Thursday, after two consecutive sessions in a row of losses. AEX-Index dropped 0.77% to €739.71, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, GEOJUNXION has a trailing twelve months EPS of €-0.19.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.12%.

More news about GEOJUNXION.

7. FOUNTAIN (FOU.BR)

6.96% Price Change

Fountain S.A. engages in the sale, rental, and provision of machines for cold and hot drinks made from freeze-dried or grain products in Europe. It provides coffee and cartridge machines, and other beverages machines. The company offers its products through independent distributors. Fountain S.A. was founded in 1972 and is based in Braine-l'Alleud, Belgium.

BEL 20 ended the session with FOUNTAIN jumping 6.96% to €1.23 on Thursday, after five sequential sessions in a row of losses. BEL 20 fell 0.76% to €3,645.47, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, FOUNTAIN has a trailing twelve months EPS of €-0.14.

Volume

Today’s last reported volume for FOUNTAIN is 1000 which is 34.4% above its average volume of 744.

Volatility

FOUNTAIN’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.87%, a negative 1.46%, and a positive 4.36%.

FOUNTAIN’s highest amplitude of average volatility was 0.87% (last week), 2.63% (last month), and 4.36% (last quarter).

More news about FOUNTAIN.

8. CARASENT (CARA.OL)

5.69% Price Change

Carasent ASA provides cloud-based medical record services to the health care industry in the Nordic region. The company offers Webdoc, a digital electronic health record (EHR) system; Vårdrummet, a digital platform for communication between patients and therapists, as well as care givers; and Ad Curis, a journal and professional system that delivers forward-thinking services to rehabilitation, substance abuse treatment, and mental health care, as well as organizations within upbringing and preventive works. It also provides Metodika EPM, a solution for medium sized private clinics and hospitals; Medrave M4, a program that offers healthcare professionals with an overview of the patient treatment group; Confrere, a video solution for physicians; and Plustoo, a software solution that collects, analyses, and visualizes data, as well as enables occupational health providers, employers, and employees to collaborate for healthy and sustainable work environment. In addition, the company provides Ad Voca; and Ad Opus, a system that structures work processes to follow-up participants in a course of measures for companies that work with inclusion into working life. Carasent ASA was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. The company was founded in 1997 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with CARASENT jumping 5.69% to €13.38 on Thursday, after two consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI fell 0.6% to €1,262.20, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, CARASENT has a trailing twelve months EPS of kr-0.63.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.05%.

More news about CARASENT.

9. BPOST (BPOST.BR)

5.18% Price Change

bpost NV/SA, together with its subsidiaries, provides mail and parcel services to individuals, businesses, and public institutions in Belgium, rest of Europe, the United States, and internationally. It operates through Belgium, E-Logistics Eurasia, E-Logistics North America, and Corporate segments. The company offers collection, transport, sorting, and distribution of addressed and non-addressed mail, printed documents, newspapers, periodicals, and parcels, as well as banking and financial products, e-commerce logistics, express delivery, proximity and convenience, document management, and related services. It also provides transactional mails, advertising mails, press, domestic and international parcels, logistic solutions, and cross-border products, as well as value-added services. The company was incorporated in 1830 and is headquartered in Brussels, Belgium.

BEL 20 ended the session with BPOST jumping 5.18% to €4.71 on Thursday while BEL 20 slid 0.76% to €3,645.47.

Earnings Per Share

As for profitability, BPOST has a trailing twelve months EPS of €0.96.

PE Ratio

BPOST has a trailing twelve months price to earnings ratio of 4.91. Meaning, the purchaser of the share is investing €4.91 for every euro of annual earnings.

Volume

Today’s last reported volume for BPOST is 280686 which is 27.93% above its average volume of 219392.

Volatility

BPOST’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.78%, a negative 0.05%, and a positive 1.20%.

BPOST’s highest amplitude of average volatility was 0.80% (last week), 1.07% (last month), and 1.20% (last quarter).

More news about BPOST.

10. ADOCIA (ADOC.PA)

5.14% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA rising 5.14% to €10.64 on Thursday, after two sequential sessions in a row of losses. CAC 40 jumped 0.03% to €7,196.10, after five sequential sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-0.82.

Volatility

ADOCIA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.98%, a positive 2.80%, and a positive 7.39%.

ADOCIA’s highest amplitude of average volatility was 6.20% (last week), 8.11% (last month), and 7.39% (last quarter).

Moving Average

ADOCIA’s value is way above its 50-day moving average of €4.06 and way above its 200-day moving average of €3.59.

More news about ADOCIA.

Losers Today

1. ABIVAX (ABVX.PA)

-8.62% Price Change

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics to treat patients with chronic inflammatory diseases, viral infections, and cancer. The company's lead drug candidate is obefazimod that is in Phase 3 clinical trials for the treatment of ulcerative colitis. It is also advancing various preclinical candidates for the treatment of additional inflammatory diseases, as well as viral infections. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.

CAC 40 ended the session with ABIVAX dropping 8.62% to €17.38 on Thursday, after three consecutive sessions in a row of gains. CAC 40 rose 0.03% to €7,196.10, after five sequential sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, ABIVAX has a trailing twelve months EPS of €-2.82.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -315.24%.

Moving Average

ABIVAX’s worth is above its 50-day moving average of €16.55 and way above its 200-day moving average of €10.37.

Volatility

ABIVAX’s last week, last month’s, and last quarter’s current intraday variation average was 2.15%, 0.61%, and 2.01%.

ABIVAX’s highest amplitude of average volatility was 3.14% (last week), 1.83% (last month), and 2.01% (last quarter).

More news about ABIVAX.

2. LAVIDE HOLDING (LVIDE.AS)

-6.36% Price Change

Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. was incorporated in 1998 and is based in Sluis, the Netherlands.

AEX-Index ended the session with LAVIDE HOLDING dropping 6.36% to €0.21 on Thursday, after two sequential sessions in a row of losses. AEX-Index fell 0.77% to €739.71, after two sequential sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.04.

Yearly Top and Bottom Value

LAVIDE HOLDING’s stock is valued at €0.21 at 22:40 EST, way below its 52-week high of €0.51 and way above its 52-week low of €0.14.

Moving Average

LAVIDE HOLDING’s value is way under its 50-day moving average of €0.28 and way below its 200-day moving average of €0.33.

More news about LAVIDE HOLDING.

3. ATOS (ATO.PA)

-5.67% Price Change

Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms. The company also provides advance detection and response, data protection and governance, digital workplace security, IoT and OT security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. It serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, telecom, media, and entertainment industries. The company was incorporated in 1982 and is headquartered in Bezons, France.

CAC 40 ended the session with ATOS dropping 5.67% to €7.41 on Thursday while CAC 40 jumped 0.03% to €7,196.10.

Earnings Per Share

As for profitability, ATOS has a trailing twelve months EPS of €-10.08.

More news about ATOS.

4. NORDIC SEMICONDUC (NOD.OL)

-5.4% Price Change

Nordic Semiconductor ASA, a fabless semiconductor company, designs, sells, and delivers integrated circuits (ICs) and related products and services for use in short- and long- range wireless applications in Europe, the Americas, and the Asia/Pacific. The company offers bluetooth and multiprotocol Systems-on-Chip (SoCs) that provides short-range connectivity; and Systems-in-Package (SiPs), which offers connectivity on long-range LTE-M and NB-IoT cellular networks. It also provides nRF9160 SiP low power cellular IoT device, nRF Cloud solution, nRF Connect software development kit, and third-party cellular modules; DECT NR+, a non-cellular radio standard; nRF7002 Wi-Fi companion ICs; and nRF52840 and nRF5340 multiprotocol SoCs. In addition, the company offers Bluetooth mesh; Bluetooth direction finding solution; Bluetooth Low Energy SoCs; Bluetooth LE audio products; Matter, a Connected Home over IP solution; Thread, an IP-based wireless networking protocol solution; Zigbee products; ANT solutions, including wireless multiprotocol SoCs supporting the ANT wireless protocol; pre-certified development modules and modems; and range extenders. Further, it provides built-in power management on SoCs and dedicated power management ICs comprising nPM1100 PMIC, nPM1300 PMIC, nPM6001 PMIC, nPM1100 EK, and Power Profiler Kit II; Device-to-nRF Cloud and Cloud-to-nRF Cloud solutions; and application specific integrated circuits and related consulting services. The company's products are used in various applications, such as automotive, beacon, computer peripherals, connected health, connected home, education, industrial automation, LED lighting, logistics and transport, retail and payment, sports and fitness, toys and gaming, virtual reality and augmented reality products, and wearables. Nordic Semiconductor ASA was founded in 1983 and is headquartered in Trondheim, Norway.

Oslo Børs Benchmark Index_GI ended the session with NORDIC SEMICONDUC dropping 5.4% to €120.10 on Thursday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI dropped 0.6% to €1,262.20, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, NORDIC SEMICONDUC has a trailing twelve months EPS of kr4.2.

PE Ratio

NORDIC SEMICONDUC has a trailing twelve months price to earnings ratio of 28.6. Meaning, the purchaser of the share is investing kr28.6 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.15%.

More news about NORDIC SEMICONDUC.

5. BORGESTAD (BOR.OL)

-5.05% Price Change

Borgestad ASA develops, manufactures, distributes, and installs refractory products in Norway. The company also develops and manages real estate properties. Its properties include Agora Bytom, a shopping center with a gross area of 52,000 square meters and a rental area of approximately 30,000 square meters, as well as a parking garage with 820 parking lots in Poland. Borgestad ASA was founded in 1904 and is headquartered in Skien, Norway.

Oslo Børs Benchmark Index_GI ended the session with BORGESTAD falling 5.05% to €1.41 on Thursday while Oslo Børs Benchmark Index_GI fell 0.6% to €1,262.20.

Earnings Per Share

As for profitability, BORGESTAD has a trailing twelve months EPS of kr-0.82.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.11%.

Moving Average

BORGESTAD’s value is below its 50-day moving average of kr1.50 and under its 200-day moving average of kr1.46.

Revenue Growth

Year-on-year quarterly revenue growth grew by 31.8%, now sitting on 1.02B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 400% and 100%, respectively.

Sales Growth

BORGESTAD’s sales growth is 6.6% for the present quarter and 4% for the next.

More news about BORGESTAD.

6. KOMPLETT (KOMPL.OL)

-5% Price Change

Komplett ASA operates as an online retailer of electronics and IT products in Norway, Sweden, and Denmark. The company operates through three segments: Business to Consumer (B2C), Business to Business (B2B), and Distribution. It offers consumer electronics and business solutions, including computer components, gaming, PCs, household electronics, and other computer-related products, as well as brown and white goods, and cloud-based IT solutions and services. It operates webshops under the Komplett brand; and retail stores under the Webhallen brand. The company's B2B operations include sales to companies and public entities/institutions under the Komplett Bedrift and Komplett Företag. It also distributes products to resellers and other entities under the Itegra brand. The company was formerly known as Norkom ASA and changed its name to Komplett ASA in December 2002. Komplett ASA was founded in 1991 and is headquartered in Sandefjord, Norway.

Oslo Børs Benchmark Index_GI ended the session with KOMPLETT dropping 5% to €9.31 on Thursday while Oslo Børs Benchmark Index_GI fell 0.6% to €1,262.20.

Earnings Per Share

As for profitability, KOMPLETT has a trailing twelve months EPS of kr-1.68.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.63%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, KOMPLETT’s stock is considered to be oversold (<=20).

More news about KOMPLETT.

7. ATLANTIC SAPPHIRE (ASA.OL)

-4.65% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the land-based salmon farming business. It operates through two segments, Fish Farming (Denmark); and Fish Farming (US). The company is involved in the production and sale of salmon. It operates in the United States, Denmark, and internationally. The company was founded in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE falling 4.65% to €1.72 on Thursday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI dropped 0.6% to €1,262.20, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-6.06.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATLANTIC SAPPHIRE’s stock is considered to be overbought (>=80).

Volatility

ATLANTIC SAPPHIRE’s last week, last month’s, and last quarter’s current intraday variation average was a negative 10.23%, a negative 2.72%, and a positive 3.74%.

ATLANTIC SAPPHIRE’s highest amplitude of average volatility was 10.78% (last week), 4.96% (last month), and 3.74% (last quarter).

More news about ATLANTIC SAPPHIRE.

8. CELYAD ONCOLOGY (CYAD.BR)

-4.6% Price Change

Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical trial to treat relapsed / refractory multiple myeloma; and CYAD-02, an autologous CAR-T candidate that is in Phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery Group plc for the use of its shRNA reagents to reduce expression of one or more defined targets. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with CELYAD ONCOLOGY falling 4.6% to €0.79 on Thursday, after three sequential sessions in a row of losses. BEL 20 dropped 0.76% to €3,645.47, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, CELYAD ONCOLOGY has a trailing twelve months EPS of €-1.59.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CELYAD ONCOLOGY’s stock is considered to be overbought (>=80).

More news about CELYAD ONCOLOGY.

9. REC SILICON (RECSI.OL)

-4.3% Price Change

REC Silicon ASA, together with its subsidiaries, produces and sells silicon materials for the solar and electronics industries worldwide. It offers various solar grade polysilicon for solar applications, including NextSi used for multi crystalline and monocrystalline solar ingot and wafer production in the manufacturing of solar modules. The company provides electronic grade polysilicon comprising Float Zone based devices that are used in motor control and power conversion processes for hybrid and electric vehicles, wind energy, and high voltage transmission, 5G communications, high-speed trains, Internet of Things, and big data; and Czochralski, an electronic grade polysilicon that principally used in manufacturing of semiconductor wafers. In addition, it offers silicon gases consisting of silane, dichlorosilane, monochlorosilane, and disilane. The company was formerly known as Renewable Energy Corporation ASA and changed its name to REC Silicon ASA in October 2013. REC Silicon ASA was founded in 1996 and is headquartered in Lysaker, Norway.

Oslo Børs Benchmark Index_GI ended the session with REC SILICON falling 4.3% to €17.01 on Thursday while Oslo Børs Benchmark Index_GI fell 0.6% to €1,262.20.

Earnings Per Share

As for profitability, REC SILICON has a trailing twelve months EPS of kr-2.68.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -152.8%.

More news about REC SILICON.

10. MIKO (MIKO.BR)

-4.23% Price Change

Miko NV, together with its subsidiaries, owns and manages coffee services in Belgium, France, the Netherlands, the United Kingdom, Germany, Denmark, Norway, Sweden, Poland, the Czech Republic, Slovakia, and Australia. It also places coffee and vending machines for companies, public institutions, and universities. The company offers a range of soft drinks, snacks, and healthy snacks, as well as milk, tea, and hot chocolates; and technical services. Miko NV was founded in 1801 and is based in Turnhout, Belgium.

BEL 20 ended the session with MIKO dropping 4.23% to €68.00 on Thursday, after two sequential sessions in a row of gains. BEL 20 slid 0.76% to €3,645.47, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, MIKO has a trailing twelve months EPS of €-0.47.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.21%.

Yearly Top and Bottom Value

MIKO’s stock is valued at €68.00 at 22:40 EST, way below its 52-week high of €97.40 and higher than its 52-week low of €67.50.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MIKO’s stock is considered to be oversold (<=20).

More news about MIKO.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *